/

Erypeg – Pegylated Recombinant Human Erythropoietin Injection

International Name :
Erypeg
Active Ingredient :
Pegylated Recombinant Human Erythropoietin
Manufacturer :
Intas Pharmaceuticals Ltd
Form :
Injection
Packing :
SYR/PFS
Strength :
50mcg/75mg

Description

Pegylated Recombinant Human Erythropoietin (Erypeg) Injection – Treatment for Anemia Caused by Chronic Kidney Disease or Cancer Chemotherapy

Erypeg 50mcg/75mg injection is a drug that is used to treat anemia caused by chronic renal disease or cancer chemotherapy. Erypeg injection is available in two strengths: 50mcg and 75mg. It works by activating bone marrow stem cells to boost red blood cell synthesis. Simultaneously, it works on red blood cells to keep them from being destroyed.

Erypeg injection is normally given by a doctor or a nurse. This drug should not be self-administered at home. The dosage is determined by your weight and the cause of anemia. Take the injections on a regular basis until you’ve finished the entire dose. Iron supplementation, both before and during therapy, may improve the effectiveness of this medication.

Fedelty Health Care is a  Pegylated Recombinant Human Erythropoietin wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.

USES OF PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN (ERYPEG) 50MCG/75MG INJECTION
  • Treatment of Anemia due to chronic kidney disease
  • Treatment of Anemia due to cancer chemotherapy
WORKS OF PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN (ERYPEG) 50MCG/75MG INJECTION

Erypeg Erythropoietin, a hormone generated mostly by specialized cells in the kidney, is contained in the injection. It protects red blood cells from being destroyed by acting on them. Simultaneously, it stimulates bone marrow stem cells to boost red blood cell formation and maintains equilibrium in oxygen supply to bodily tissue.

Fedelty Health Care is a  Pegylated Recombinant Human Erythropoietin wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.

SIDE EFFECTS OF PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN (ERYPEG) 50MCG/75MG INJECTION
  • Nausea
  • Vomiting
  • Diarrhea
  • Fever
WARNING & PRECAUTIONS
  • Driving

It is unknown whether Erypeg Injection affects driving abilities. If you have any symptoms that impair your ability to focus or respond, don’t drive.

  • Kidney

On the usage of Erypeg Injection in individuals with renal disease, there is minimal information. Please seek medical advice.

  • Liver

On the usage of Erypeg Injection in individuals with liver disease, there is minimal information. Please seek medical advice.

  • Pregnancy

There is no information on the usage of Erypeg Injection during pregnancy. Please seek medical advice.

  • Breastfeeding

There is no information on the usage of Erypeg Injection while nursing. Please seek medical advice.

Fedelty Health Care is a  Pegylated Recombinant Human Erythropoietin third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.

    Reviews

    There are no reviews yet.

    Be the first to review “Erypeg – Pegylated Recombinant Human Erythropoietin Injection”

    Your email address will not be published. Required fields are marked *